What CVD outcomes were seen in the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)?
The ACE-I perindopril, as compared with placebo, decreased the rate of recurrent stroke in patients with CKD in the Perindopril Protection Against Recurrent Stroke Study (PROGRESS).